NDC 42976-121

ATryn

Antithrombin Recombinant

ATryn is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Revo Biologics, Inc.. The primary component is Antithrombin Alfa.

Product ID42976-121_634fb454-4f7f-4b30-9f89-fd3a122cf074
NDC42976-121
Product TypeHuman Prescription Drug
Proprietary NameATryn
Generic NameAntithrombin Recombinant
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2009-05-06
Marketing CategoryBLA / BLA
Application NumberBLA125284
Labeler NamerEVO Biologics, Inc.
Substance NameANTITHROMBIN ALFA
Active Ingredient Strength1750 [iU]/mL
Pharm ClassesDecreased Coagulation Factor Activity [PE],Thrombin Inhibitors [MoA],Factor Xa Inhibitors [MoA],Recombinant Antithrombin [EPC]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 42976-121-02

1 VIAL in 1 CARTON (42976-121-02) > 3 mL in 1 VIAL
Marketing Start Date2009-05-06
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 42976-121-02 [42976012102]

ATryn INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Marketing CategoryBLA
Application NumberBLA125284
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2009-05-06
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
ANTITHROMBIN ALFA1750 [iU]/1

OpenFDA Data

SPL SET ID:ed3eaf69-1cbd-4b01-a6fa-1fe02c90c3e1
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1661563
  • 1661566
  • Pharmacological Class

    • Decreased Coagulation Factor Activity [PE]
    • Thrombin Inhibitors [MoA]
    • Factor Xa Inhibitors [MoA]
    • Recombinant Antithrombin [EPC]

    NDC Crossover Matching brand name "ATryn" or generic name "Antithrombin Recombinant"

    NDCBrand NameGeneric Name
    42976-121ATrynAntithrombin Recombinant
    42976-125ATrynAntithrombin Recombinant

    Trademark Results [ATryn]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    ATRYN
    ATRYN
    76184729 2743233 Live/Registered
    REVO BIOLOGICS, INC.
    2000-12-20

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.